Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
OTCMKTS:DCTHD

Delcath Systems (DCTHD) Stock Price, News & Analysis

Delcath Systems logo

About Delcath Systems Stock (OTCMKTS:DCTHD)

Key Stats

Today's Range
$10.84
$11.28
50-Day Range
N/A
52-Week Range
$1.22
$63,000.00
Volume
458,908 shs
Average Volume
771 shs
Market Capitalization
$440,400.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Delcath Systems, Inc. is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company's system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

Receive DCTHD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Delcath Systems and its competitors with MarketBeat's FREE daily newsletter.

DCTHD Stock News Headlines

The #1 Coin for November 2024
Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
Delcath Systems reports Q3 EPS 6c, consensus (20c)
See More Headlines

DCTHD Stock Analysis - Frequently Asked Questions

Delcath Systems, Inc. (OTCMKTS:DCTHD) posted its quarterly earnings data on Friday, November, 11th. The medical device company reported ($231.00) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1,151.50) by $920.50. The medical device company had revenue of $0.44 million for the quarter.

Delcath Systems shares reverse split before market open on Monday, November 6th 2017. The 1-350 reverse split was announced on Friday, November 3rd 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 3rd 2017. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Company Calendar

Last Earnings
11/11/2016
Today
12/22/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:DCTHD
Previous Symbol
NASDAQ:DCTH
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-19,220,000.00
Net Margins
-1,546.38%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.41 million
Book Value
($1,036.00) per share

Miscellaneous

Free Float
N/A
Market Cap
$440,400.00
Optionable
Not Optionable
Beta
-0.03
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:DCTHD) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners